July 7, 2004 -- Enoxaparin is noninferior to unfractionated heparin for the treatment of acute coronary syndromes (ACS), according to the results of two large studies published in the July 7 issue of ...

Please provide your email address to receive an email when new articles are posted on . “Postoperative unfractionated heparin in addition to aspirin for venous thromboembolism prophylaxis is not ...

Speaking with heart wire, Kearon noted there was indirect evidence suggesting that APTT monitoring didn't help improve the efficacy or safety of using unfractionated heparin if the patient had been ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Enoxaparin was superior to unfractionated heparin, with a 43% relative risk reduction of venous ...

McGarry and colleagues did an excellent job in providing an economic perspective on the effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ...

(UPDATED) The MATRIX trial found no advantage to bivalirudin over unfractionated heparin in reducing major adverse cardiovascular events (MACE) or net adverse cardiovascular events (NACE) in ACS ...

18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious Episodes Two hundred and ...

The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to ...

White HD, Chew DP, Hoekstra JW, et al. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary ...

Global Heparin Market OverviewThe global heparin market is projected to expand at a steady compound annual growth rate of around 5% through 2031, supported by the rising burden of chronic and ...